Dabur India FY25 Annual Earnings Summary
4 quarters covered · ₹12,563 Cr revenue · ₹1,741 Cr PAT · 3.8% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY25Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY25Risks flagged during the year
Bajaj and Emami have become aggressive in coconut oil, leading to margin squeeze and price corrections. Dabur's Sarson Amla underperformed due to softening mustard oil prices.
Q2 FY25 · highHigh food inflation (~9%) is shifting consumer spending from discretionary to essentials, potentially delaying urban recovery.
Q2 FY25 · highPrice gap between juices and carbonated drinks (e.g., Campa Cola at INR 45/liter vs Real at INR 130/liter) is causing category decline and may persist.
Q3 FY25 · highInflation expected to rise to ~5% in FY26, impacting gross margins if not fully offset by price increases.
Q3 FY25 · highCampa Cola's aggressive pricing and trade margins are pressuring Dabur's nectar portfolio, especially in out-of-home consumption.
Q4 FY25 · highBeverage segment faces heightened competition from Campa Cola and others, with management expecting only low to mid-single-digit growth in FY26.
Q1 FY25 · mediumPrice premium of nectars vs colas widened from 2.2x to 3.2x due to aggressive pricing by new cola entrants, impacting nectar growth despite market share gains.
Q1 FY25 · mediumCurrency devaluation in Egypt, Nigeria, and Turkey impacted INR growth despite strong constant currency performance. CFO expects overlap by Q3.
Q1 FY25 · mediumWhile rural recovery is visible in UP, Bihar, and Central India, South India continues to face demand weakness, which could weigh on overall growth.
Q2 FY25 · mediumCurrency depreciation in Egypt and Turkey caused a translation loss of INR 181 crore in H1, impacting reported international profitability.
Q2 FY25 · mediumDistributors are unhappy with Dabur supplying directly to quick commerce players, potentially affecting GT relationships and margins.
Q3 FY25 · mediumUrban consumption growth has moderated to ~5%, impacting categories like juices and healthcare supplements.
What changed through the year
Q1 FY25 · Volume growth expected to improve sequentially
Management expects volume growth to continue picking up in subsequent quarters, driven by rural recovery and government spending.
Q1 FY25 · Gross margin improvement of 120 bps partly reinvested
Around 80% of gross margin gains will be reinvested into advertising and promotion, with balance flowing to operating margin.
Q1 FY25 · Home care target of INR 1,000 crore
Management aims to grow home care (Odomos, Odonil) from ~INR 800 crore to INR 1,000 crore by expanding total addressable market.
Q1 FY25 · Legal costs for Namaste case to reduce
Legal costs expected to be ~INR 80 crore for FY25 vs INR 100 crore last year, with potential insurance recovery of 50%.
Q2 FY25 · H2 FY25 revenue growth of mid-to-high single digits
Management expects second-half revenue growth to return to mid-to-high single digits, subject to good winters and normal FMCG demand.
Q2 FY25 · Distributor inventory target of 19 days by December 2024
Management aims to reduce distributor inventory from 21 days to around 19 days by end of December 2024.
Q2 FY25 · Home care portfolio to reach INR 1,000 crore in 2-3 years
Management expects the home care portfolio to grow from INR 700 crore to INR 1,000 crore in a two- to three-year time frame.
Q2 FY25 · Sesa acquisition to deliver 18-19% operating margin post-synergies
Post-merger, Sesa's operating margin is expected to inch up to 18-19%, similar to Dabur, once synergies are realized.
Q3 FY25 · Mid-single-digit value growth in Q4 FY25
Management expects sequential improvement and mid-single-digit value growth in Q4, driven by price increases and volume recovery.
Q3 FY25 · Margin maintenance in Q4 FY25
Management aims to maintain current margin levels in Q4 through price increases and cost savings.
Q3 FY25 · Inflation mitigation through price increases
Expects ~5% inflation and plans calibrated price increases across categories to offset input cost pressures.
Q3 FY25 · Strategic vision revision with McKinsey
Partnered with McKinsey to refine three-year strategy, focusing on beverages and healthcare; exercise to conclude by end of FY25.
Q4 FY25 · High single-digit value growth for FY26
Management expects full-year FY26 India business to achieve high single-digit value growth, with sequential improvement through the year.
Q4 FY25 · Sustainable double-digit CAGR by FY28
Dabur aims to achieve sustainable double-digit CAGR in both top line and bottom line by financial year 2028.
Q4 FY25 · Exit from tea, diapers, and Vita categories
Management plans to exit tea, baby diapers, and Vita (MFD) categories, which are margin-dilutive and contribute less than 1% of revenue.